BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9738976)

  • 21. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene.
    Thompson AD; Braun BS; Arvand A; Stewart SD; May WA; Chen E; Korenberg J; Denny C
    Oncogene; 1996 Dec; 13(12):2649-58. PubMed ID: 9000139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis.
    Leacock SW; Basse AN; Chandler GL; Kirk AM; Rakheja D; Amatruda JF
    Dis Model Mech; 2012 Jan; 5(1):95-106. PubMed ID: 21979944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma.
    Kinsey M; Smith R; Iyer AK; McCabe ER; Lessnick SL
    Cancer Res; 2009 Dec; 69(23):9047-55. PubMed ID: 19920188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.
    Ginsberg JP; de Alava E; Ladanyi M; Wexler LH; Kovar H; Paulussen M; Zoubek A; Dockhorn-Dworniczak B; Juergens H; Wunder JS; Andrulis IL; Malik R; Sorensen PH; Womer RB; Barr FG
    J Clin Oncol; 1999 Jun; 17(6):1809-14. PubMed ID: 10561219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts.
    Ouchida M; Ohno T; Fujimura Y; Rao VN; Reddy ES
    Oncogene; 1995 Sep; 11(6):1049-54. PubMed ID: 7566963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In situ reverse-transcriptase polymerase chain reaction demonstration of the EWS/FLI-1 fusion transcript in Ewing's sarcomas and peripheral primitive neuroectodermal tumors.
    Krams M; Peters J; Boeckel F; Raether A; Ambros PF; Parwaresch R; Harms D
    Virchows Arch; 2000 Sep; 437(3):234-40. PubMed ID: 11037342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutant screening for oncogenes of Ewing's sarcoma using yeast.
    Kitagawa T; Okita H; Baron B; Tokuda K; Nakamura M; Wang Y; Akada J; Hoshida H; Akada R; Kuramitsu Y; Nakamura K
    Appl Microbiol Biotechnol; 2015 Aug; 99(16):6737-44. PubMed ID: 25936378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biology of EWS/FLI and related fusion genes in Ewing's sarcoma and primitive neuroectodermal tumor.
    May WA; Denny CT
    Curr Top Microbiol Immunol; 1997; 220():143-50. PubMed ID: 9103680
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of Ewing's sarcoma using an antisense oligodeoxynucleotide to regulate the cell cycle.
    Asami S; Chin M; Shichino H; Yoshida Y; Nemoto N; Mugishima H; Suzuki T
    Biol Pharm Bull; 2008 Mar; 31(3):391-4. PubMed ID: 18310898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A method for accurate detection of translocation junctions in Ewing family of tumors.
    Morishita T; Bolander ME; Zhang K; Tamai S; Mii Y; Sarkar G
    Mol Biotechnol; 2001 Jun; 18(2):97-104. PubMed ID: 11471459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of the EWS NH2 terminus with BARD1 links the Ewing's sarcoma gene to a common tumor suppressor pathway.
    Spahn L; Petermann R; Siligan C; Schmid JA; Aryee DN; Kovar H
    Cancer Res; 2002 Aug; 62(16):4583-7. PubMed ID: 12183411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma.
    Ban J; Jug G; Mestdagh P; Schwentner R; Kauer M; Aryee DN; Schaefer KL; Nakatani F; Scotlandi K; Reiter M; Strunk D; Speleman F; Vandesompele J; Kovar H
    Oncogene; 2011 May; 30(18):2173-80. PubMed ID: 21217773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic significance and clinical applications of chimeric genes in Ewing's sarcoma.
    Yoshino N; Kojima T; Asami S; Motohashi S; Yoshida Y; Chin M; Shichino H; Yoshida Y; Nemoto N; Kaneko M; Mugishima H; Suzuki T
    Biol Pharm Bull; 2003 May; 26(5):585-8. PubMed ID: 12736494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.
    Lessnick SL; Braun BS; Denny CT; May WA
    Oncogene; 1995 Feb; 10(3):423-31. PubMed ID: 7845667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An EWS/ERG fusion with a truncated N-terminal domain of EWS in a Ewing's tumor.
    Peter M; Mugneret F; Aurias A; Thomas G; Magdelenat H; Delattre O
    Int J Cancer; 1996 Jul; 67(3):339-42. PubMed ID: 8707406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors.
    Vural C; Uluoğlu O; Akyürek N; Oğuz A; Karadeniz C
    Pathol Oncol Res; 2011 Sep; 17(3):619-25. PubMed ID: 21267687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ewing's tumours, genetic and cellular aspects].
    Delattre O
    Pathol Biol (Paris); 2008 Jul; 56(5):257-9. PubMed ID: 18485618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EWS/ETS fusion genes induce epithelial and neuroectodermal differentiation in NIH 3T3 fibroblasts.
    Teitell MA; Thompson AD; Sorensen PH; Shimada H; Triche TJ; Denny CT
    Lab Invest; 1999 Dec; 79(12):1535-43. PubMed ID: 10616204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift.
    Bridge JA; Fidler ME; Neff JR; Degenhardt J; Wang M; Walker C; Dorfman HD; Baker KS; Seemayer TA
    Am J Surg Pathol; 1999 Feb; 23(2):159-65. PubMed ID: 9989842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma.
    Smith R; Owen LA; Trem DJ; Wong JS; Whangbo JS; Golub TR; Lessnick SL
    Cancer Cell; 2006 May; 9(5):405-16. PubMed ID: 16697960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.